Miguel Muñoz

3.3k total citations
71 papers, 2.3k citations indexed

About

Miguel Muñoz is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Miguel Muñoz has authored 71 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cellular and Molecular Neuroscience, 35 papers in Molecular Biology and 31 papers in Psychiatry and Mental health. Recurrent topics in Miguel Muñoz's work include Neuropeptides and Animal Physiology (53 papers), Cancer, Stress, Anesthesia, and Immune Response (31 papers) and Receptor Mechanisms and Signaling (22 papers). Miguel Muñoz is often cited by papers focused on Neuropeptides and Animal Physiology (53 papers), Cancer, Stress, Anesthesia, and Immune Response (31 papers) and Receptor Mechanisms and Signaling (22 papers). Miguel Muñoz collaborates with scholars based in Spain, United States and Germany. Miguel Muñoz's co-authors include Rafael Coveñas, Marisa Rosso, Ana González-Ortega, Francisco Esteban, Maximino Redondo, Michael Berger, Manuel Vicente Salinas-Martín, Andrés Carranza Carranza, Miguel Ángel González‐Moles and Aleida Pérez and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Hepatology and International Journal of Environmental Research and Public Health.

In The Last Decade

Miguel Muñoz

67 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miguel Muñoz Spain 29 1.3k 1.0k 914 579 344 71 2.3k
Joseph R. Pisegna United States 24 1.3k 1.0× 1.0k 1.0× 102 0.1× 619 1.1× 687 2.0× 53 2.6k
Igor Feoktistov United States 35 606 0.5× 1.8k 1.7× 247 0.3× 517 0.9× 145 0.4× 62 4.6k
Kiyonobu Ikezaki Japan 27 307 0.2× 469 0.5× 935 1.0× 153 0.3× 243 0.7× 84 2.7k
Per Almqvist Sweden 27 585 0.4× 646 0.6× 143 0.2× 121 0.2× 103 0.3× 68 1.7k
Maria Maryanovich United States 11 226 0.2× 755 0.7× 343 0.4× 216 0.4× 104 0.3× 31 1.7k
Tara Karnezis Australia 24 296 0.2× 1.1k 1.1× 230 0.3× 1.4k 2.4× 62 0.2× 35 2.6k
Christopher Lindberg Sweden 30 660 0.5× 1.4k 1.3× 158 0.2× 65 0.1× 800 2.3× 93 2.6k
Michael R. Fetell United States 24 276 0.2× 594 0.6× 159 0.2× 359 0.6× 159 0.5× 47 2.0k
Daniela Virgintino Italy 30 400 0.3× 862 0.8× 61 0.1× 346 0.6× 171 0.5× 94 2.3k
Pascale Vertongen Belgium 21 844 0.6× 678 0.7× 141 0.2× 295 0.5× 63 0.2× 35 1.2k

Countries citing papers authored by Miguel Muñoz

Since Specialization
Citations

This map shows the geographic impact of Miguel Muñoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Muñoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Muñoz more than expected).

Fields of papers citing papers by Miguel Muñoz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miguel Muñoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Muñoz. The network helps show where Miguel Muñoz may publish in the future.

Co-authorship network of co-authors of Miguel Muñoz

This figure shows the co-authorship network connecting the top 25 collaborators of Miguel Muñoz. A scholar is included among the top collaborators of Miguel Muñoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel Muñoz. Miguel Muñoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mehboob, Riffat, Syed Amir Gilani, Imrana Tanvir, et al.. (2021). Prognostic Significance of Substance P/Neurokinin 1 Receptor and Its Association with Hormonal Receptors in Breast Carcinoma. BioMed Research International. 2021(1). 5577820–5577820. 7 indexed citations
3.
Esteban, Francisco, Pablo Ramos‐García, Miguel Muñoz, & Miguel Ángel González‐Moles. (2021). Substance P and Neurokinin 1 Receptor in Chronic Inflammation and Cancer of the Head and Neck: A Review of the Literature. International Journal of Environmental Research and Public Health. 19(1). 375–375. 16 indexed citations
4.
Esteban, Francisco, et al.. (2020). The substance P and neurokinin-1 receptor system in human thyroid cancer: an immunohistochemical study. European Journal of Histochemistry. 64(2). 17 indexed citations
5.
Muñoz, Miguel, Marisa Rosso, & Rafael Coveñas. (2019). Neurokinin-1 Receptor Antagonists against Hepatoblastoma. Cancers. 11(9). 1258–1258. 25 indexed citations
6.
Kast, Richard E., et al.. (2015). Antitumor action of temozolomide, ritonavir and aprepitant against human glioma cells. Journal of Neuro-Oncology. 126(3). 425–431. 41 indexed citations
7.
Muñoz, Miguel. (2014). Involvement of substance P and the NK-1 receptor in pancreatic cancer. World Journal of Gastroenterology. 20(9). 2321–2321. 44 indexed citations
8.
Muñoz, Miguel & Rafael Coveñas. (2014). Involvement of substance P and the NK-1 receptor in human pathology. Amino Acids. 46(7). 1727–1750. 167 indexed citations
9.
Muñoz, Miguel, Michael Berger, Marisa Rosso, et al.. (2013). Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts. International Journal of Oncology. 44(1). 137–146. 49 indexed citations
10.
Muñoz, Miguel & Rafael Coveñas. (2013). Involvement of substance P and the NK-1 receptor in cancer progression. Peptides. 48. 1–9. 125 indexed citations
11.
Alcaide, Julia, Antonio Rueda, Elísabeth Pérez-Ruiz, et al.. (2013). The role and prognostic value of apoptosis in colorectal carcinoma. BMC Clinical Pathology. 13(1). 24–24. 32 indexed citations
12.
Muñoz, Miguel, Ana González-Ortega, Marisa Rosso, et al.. (2012). The substance P/neurokinin-1 receptor system in lung cancer: Focus on the antitumor action of neurokinin-1 receptor antagonists. Peptides. 38(2). 318–325. 63 indexed citations
13.
Muñoz, Miguel & Rafael Coveñas. (2012). NK-1 Receptor Antagonists: A New Generation of Anticancer Drugs. Mini-Reviews in Medicinal Chemistry. 12(7). 593–599. 12 indexed citations
14.
Muñoz, Miguel & Rafael Coveñas. (2011). NK-1 Receptor Antagonists: A New Paradigm in Pharmacological Therapy. Current Medicinal Chemistry. 18(12). 1820–1831. 37 indexed citations
15.
Muñoz, Miguel, Ana González-Ortega, & Rafael Coveñas. (2010). The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines. Investigational New Drugs. 30(2). 529–540. 41 indexed citations
16.
Muñoz, Miguel, Marisa Rosso, Marta Salinas, et al.. (2010). Immunolocalization of NK-1 Receptor and Substance P in Human Normal Placenta. Placenta. 31(7). 649–651. 21 indexed citations
17.
González‐Moles, Miguel Ángel, Francisco Esteban, Isabel Ruiz‐Ávila, et al.. (2008). A role for the substance P/NK‐1 receptor complex in cell proliferation and apoptosis in oral lichen planus. Oral Diseases. 15(2). 162–169. 24 indexed citations
18.
Muñoz, Miguel, et al.. (2007). NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2. Investigational New Drugs. 26(2). 111–118. 69 indexed citations
19.
Muñoz, Miguel, Marisa Rosso, Aleida Pérez, et al.. (2005). The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines. Neuropeptides. 39(4). 427–432. 83 indexed citations
20.
Muñoz, Miguel, et al.. (2004). Hormona de crecimiento, destete y estado nutritivo. Anales de la Real Academia Nacional de Farmacia. 70(3). 695–725. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph R. Pisegna Breakdown of academic impact, for papers by Igor Feoktistov Breakdown of academic impact, for papers by Kiyonobu Ikezaki Breakdown of academic impact, for papers by Per Almqvist Breakdown of academic impact, for papers by Maria Maryanovich Breakdown of academic impact, for papers by Tara Karnezis Breakdown of academic impact, for papers by Christopher Lindberg Breakdown of academic impact, for papers by Michael R. Fetell Breakdown of academic impact, for papers by Daniela Virgintino Breakdown of academic impact, for papers by Pascale Vertongen
Rankless by CCL
2026